Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation
- PMID: 11358816
Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation
Abstract
To evaluate the role of Akt/PKB in non-small cell lung cancer (NSCLC) survival, we analyzed NSCLC cell lines that differed in tumor histology as well as p53, Rb, and K-ras status. Constitutive Akt/protein kinase B (PKB) activity was demonstrated in 16 of 17 cell lines by maintenance of S473 phosphorylation with serum deprivation. Additional analysis of five of 2these NSCLC lines revealed that phosphorylation of S473 and T308 correlated with in vitro kinase activity. Akt/PKB activation was phosphatidylinositol 3-kinase-dependent and promoted survival because the phosphatidylinositol 3 inhibitors LY294002 and wortmannin inhibited Akt/PKB phosphorylation, Akt/PKB activity, and increased apoptosis only in cells with active Akt/PKB. To test whether Akt/PKB activity promoted therapeutic resistance, LY294002 was added with individual chemotherapeutic agents or irradiation. LY294002 greatly potentiated chemotherapy-induced apoptosis in cells with high Akt/PKB levels, but did not significantly increase chemotherapy-induced apoptosis in cells with low Akt/PKB levels. Combined with radiation in cells with active Akt/PKB, LY294002 additively increased apoptosis and inhibited clonogenic growth. These results were extended with transiently transfected Akt/PKB mutants. Transfecting dominant negative Akt/PKB decreased Akt/PKB activity and increased basal apoptosis as well as chemotherapy- and irradiation-induced apoptosis only in cells with high Akt/PKB activity. Conversely, transfecting constitutively active Akt/PKB into cells with low Akt/PKB activity increased Akt/PKB activity and attenuated chemotherapy- and radiation-induced apoptosis. We therefore identify Akt/PKB as a constitutively active kinase that promotes survival of NSCLC cells and demonstrate that modulation of Akt/PKB activity by pharmacological or genetic approaches alters the cellular responsiveness to therapeutic modalities typically used to treat patients with NSCLC.
Similar articles
-
Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.Cancer Res. 2002 Sep 1;62(17):4929-37. Cancer Res. 2002. PMID: 12208743
-
Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance.Cancer Res. 2004 May 15;64(10):3486-90. doi: 10.1158/0008-5472.CAN-03-1788. Cancer Res. 2004. PMID: 15150102
-
Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance.J Biol Chem. 2001 Oct 19;276(42):38361-9. doi: 10.1074/jbc.M103321200. Epub 2001 Jul 18. J Biol Chem. 2001. Retraction in: J Biol Chem. 2002 Aug 16;277(33):30408. PMID: 11461904 Retracted.
-
Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase--significance for diabetes and cancer.Pharmacol Ther. 1999 May-Jun;82(2-3):409-25. doi: 10.1016/s0163-7258(98)00071-0. Pharmacol Ther. 1999. PMID: 10454216 Review.
-
The activation of Akt/PKB signaling pathway and cell survival.J Cell Mol Med. 2005 Jan-Mar;9(1):59-71. doi: 10.1111/j.1582-4934.2005.tb00337.x. J Cell Mol Med. 2005. PMID: 15784165 Free PMC article. Review.
Cited by
-
Effect of PF-02341066 and radiation on non-small cell lung cancer cells.Oncol Rep. 2013 Mar;29(3):1094-100. doi: 10.3892/or.2012.2198. Epub 2012 Dec 18. Oncol Rep. 2013. PMID: 23254764 Free PMC article.
-
d-3-Deoxy-dioctanoylphosphatidylinositol induces cytotoxicity in human MCF-7 breast cancer cells via a mechanism that involves downregulation of the D-type cyclin-retinoblastoma pathway.Biochim Biophys Acta. 2016 Nov;1861(11):1808-1815. doi: 10.1016/j.bbalip.2016.09.001. Epub 2016 Sep 4. Biochim Biophys Acta. 2016. PMID: 27600289 Free PMC article.
-
NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.Br J Cancer. 2006 Dec 18;95(12):1653-62. doi: 10.1038/sj.bjc.6603435. Epub 2006 Nov 28. Br J Cancer. 2006. PMID: 17133272 Free PMC article.
-
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.Transl Lung Cancer Res. 2019 Jun;8(3):247-257. doi: 10.21037/tlcr.2019.04.19. Transl Lung Cancer Res. 2019. PMID: 31367538 Free PMC article.
-
The role of statins in lung cancer.Arch Med Sci. 2021 Mar 18;18(1):141-152. doi: 10.5114/aoms/123225. eCollection 2022. Arch Med Sci. 2021. PMID: 35154535 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous